TAT-327 – 1mg

Overview

TAT-327 is an innovative peptide that combines the Eps8-derived peptide 327 with the TAT sequence, designed to deliver targeted therapeutic effects in cancer treatment. This unique conjugation plays a crucial role in inhibiting the Eps8/EGFR interaction, a significant factor in tumor progression. By selectively inserting into cancer cell membranes, TAT-327 demonstrates potent antitumor effects, making it an essential addition to your research and therapeutic arsenal.

Key Features

• Inhibits Eps8/EGFR interaction, crucial for tumor growth.
• Selective insertion into cancer cell membranes enhances efficacy.
• 1 mg of high-purity peptide for reliable dosing in experiments.
• Suitable for various research applications, including anticancer studies.
• Part of our extensive peptide catalog, ensuring quality and consistency.

Specifications

FAQ

What is TAT-327 used for?

TAT-327 is primarily used in cancer research to explore its antitumor properties by inhibiting critical interactions involved in tumor progression.

How does TAT-327 work?

This peptide works by inhibiting the Eps8/EGFR interaction, crucial for cancer cell signaling, and selectively targets cancer cell membranes.

Where can I find more peptides for my research?

You can browse our full range of peptides, including options like Autocamtide-2 and CREBtideto support various research applications.

Closing your research needs with TAT-327 could enhance your understanding of cancer biology and therapy development. Shop now to secure your TAT-327, 1 mg and other peptides from our comprehensive catalog, ensuring you have the highest quality products for your research.

Related Products

• PKG Substrate [RKRSRAE], Glasstide

Browse more in Peptides.